"Photosensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
| Descriptor ID |
D017319
|
| MeSH Number(s) |
D27.505.954.444.600 D27.505.954.600.710
|
| Concept/Terms |
Photosensitizing Effect- Photosensitizing Effect
- Effect, Photosensitizing
- Photosensitizing Effects
- Effects, Photosensitizing
|
Below are MeSH descriptors whose meaning is more general than "Photosensitizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Photosensitizing Agents".
This graph shows the total number of publications written about "Photosensitizing Agents" by people in this website by year, and whether "Photosensitizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Photosensitizing Agents" by people in Profiles.
-
Zeng L, Huang L, Han J, Han G. Enhancing Triplet-Triplet Annihilation Upconversion: From Molecular Design to Present Applications. Acc Chem Res. 2022 09 20; 55(18):2604-2615.
-
Li X, Xiao H, Xiu W, Yang K, Zhang Y, Yuwen L, Yang D, Weng L, Wang L. Mitochondria-Targeting MoS2-Based Nanoagents for Enhanced NIR-II Photothermal-Chemodynamic Synergistic Oncotherapy. ACS Appl Mater Interfaces. 2021 Dec 01; 13(47):55928-55938.
-
Ji Y, Jones C, Baek Y, Park GK, Kashiwagi S, Choi HS. Near-infrared fluorescence imaging in immunotherapy. Adv Drug Deliv Rev. 2020 12; 167:121-134.
-
Jadia R, Kydd J, Rai P. Remotely Phototriggered, Transferrin-Targeted Polymeric Nanoparticles for the Treatment of Breast Cancer. Photochem Photobiol. 2018 07; 94(4):765-774.
-
Ohana O, Kaiserman I, Domniz Y, Cohen E, Franco O, Sela T, Munzer G, Varssano D. Outcomes of simultaneous photorefractive keratectomy and collagen crosslinking. Can J Ophthalmol. 2018 10; 53(5):523-528.
-
Huang L, Li Z, Zhao Y, Yang J, Yang Y, Pendharkar AI, Zhang Y, Kelmar S, Chen L, Wu W, Zhao J, Han G. Enhancing Photodynamic Therapy through Resonance Energy Transfer Constructed Near-Infrared Photosensitized Nanoparticles. Adv Mater. 2017 07; 29(28).
-
Gandy J, Labadie B, Bierman D, Zachary C. Photodynamic Therapy Effectively Treats Actinic Keratoses Without Pre-Illumination Incubation Time. J Drugs Dermatol. 2017 Mar 01; 16(3):275-278.
-
Huang L, Li Z, Zhao Y, Zhang Y, Wu S, Zhao J, Han G. Ultralow-Power Near Infrared Lamp Light Operable Targeted Organic Nanoparticle Photodynamic Therapy. J Am Chem Soc. 2016 11 09; 138(44):14586-14591.
-
Vald?s PA, Moses ZB, Kim A, Belden CJ, Wilson BC, Paulsen KD, Roberts DW, Harris BT. Gadolinium- and 5-aminolevulinic acid-induced protoporphyrin IX levels in human gliomas: an ex vivo quantitative study to correlate protoporphyrin IX levels and blood-brain barrier breakdown. J Neuropathol Exp Neurol. 2012 Sep; 71(9):806-13.
-
Vald?s PA, Kim A, Brantsch M, Niu C, Moses ZB, Tosteson TD, Wilson BC, Paulsen KD, Roberts DW, Harris BT. d-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. Neuro Oncol. 2011 Aug; 13(8):846-56.